Literature DB >> 3005959

[Transarterial chemoembolization therapy of hepatocellular carcinoma using anticancer agents (mitomycin C and/or adriamycin) suspended in lipiodol].

H Hidaka, H Kobayashi, M Ohyama, T Maeda, K Ikeda, M Nakajo, T Oyama, T Sonoda, Y Ito, S Shinohara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3005959

Source DB:  PubMed          Journal:  Nihon Igaku Hoshasen Gakkai Zasshi        ISSN： 0048-0428


× No keyword cloud information.
  3 in total

1.  Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection.

Authors:  K Ikeda; H Inoue; T Yano; H Kobayashi; M Nakajo
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels.

Authors:  Andreas Schicho; Claus Hellerbrand; Kristina Krüger; Lukas P Beyer; Walter Wohlgemuth; Christoph Niessen; Ernst Hohenstein; Christian Stroszczynski; Philippe L Pereira; Philipp Wiggermann
Journal:  J Clin Transl Hepatol       Date:  2016-12-27

3.  Initial outcomes of mitomycin intravascular chemoembolization (MICE) for corneal neovascularization.

Authors:  Michael Mimouni; Dean Ouano
Journal:  Int Ophthalmol       Date:  2022-01-31       Impact factor: 2.029
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.